RxDoctor Payments DataLook up a doctor →

Cole Gillenwater, MD

Family Medicine · Wichita, KSNPI 1932557220

Payments from drug & device makers

$62,024in general payments, 2019–2025

Across 1,802 payments — averaging $34.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$45K
  • Novo Nordisk$2K
  • AbbVie$2K
  • Lilly USA, LLC$2K
  • AstraZeneca$2K
  • Pfizer$1K
  • plus $8K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
GSK116$44,683
Novo Nordisk290$2,376
AbbVie(2 entities)333$2,312
Lilly USA, LLC200$1,925
AstraZeneca57$1,616
Pfizer174$1,354
Amgen(2 entities)91$797
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC47$652
Amarin Pharma, Inc.48$588
Sanofi-aventis U.S. LLC42$543
Antares Pharma, Inc.45$500
Johnson & Johnson54$431
Boehringer Ingelheim25$329
Radius Health, Inc.16$255
Dexcom, Inc.12$226
Lundbeck LLC19$225
Eisai Inc.16$204
Sumitomo Pharma America, Inc.16$194
Abbott10$185
Biohaven Pharmaceutical Holding Company Ltd.33$183
Biohaven Pharmaceuticals, Inc.31$161
Ironshore Pharmaceuticals Inc.2$159
Novartis8$126
Idorsia Pharmaceuticals US Inc8$125
Takeda Pharmaceuticals U.S.A., Inc.7$101
Sunovion Pharmaceuticals Inc.8$101
Gilead5$97
Vanda Pharmaceuticals Inc.2$96
Teva Pharmaceuticals USA, Inc.7$96
Bayer6$94
Otsuka America Pharmaceutical, Inc.5$93
Nevro Corp.4$93
Merck6$91
Daiichi Sankyo Inc.6$86
Globus Medical2$84
Almatica Pharma LLC4$79
Esperion Therapeutics, Inc.5$74
Medtronic2$60
Nestle Healthcare Nutrition Inc.3$52
E.r. Squibb & Sons, L.L.C.3$48
Xeris Pharmaceuticals, Inc.3$47
Insulet Corporation2$44
Axsome Therapeutics, Inc.3$41
Arbor Pharmaceuticals, Inc.3$39
Corcept Therapeutics2$39
Supernus Pharmaceuticals, Inc.2$37
Inari Medical, Inc.1$37
Biogen2$28
Astellas Pharma US Inc2$27
Neos Therapeutics, LP2$26
Currax Pharmaceuticals LLC1$25
Halozyme Inc1$24
Paratek Pharmaceuticals, Inc.1$16
IBSA Pharma Inc.1$15
Cranial Technologies, Inc1$15
Alnylam Pharmaceuticals Inc.1$15
Ultragenyx Pharmaceutical Inc.1$14
Exact Sciences1$13
Upsher-smith Laboratories LLC1$12
Mylan Specialty L.p.1$11

How this compares

$62,024 in reported general payments places this provider in the 95th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$258,336
Medicare patients
609
Services billed
6,212

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Wichita

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →